|
2024
|
G/S
|
Pharmaceutical preparations for elimination of antibodies for therapeutic purposes in immune rela... |
|
2023
|
Invention
|
Co-treatment for gene therapy. The present invention relates to a method of enhancing gene therap... |
|
|
Invention
|
Regimen for enzymatic desensitisation. The present invention relates to a conditioning regimen fo... |
|
|
Invention
|
Cysteine protease. The present invention relates to a novel polypeptide which displays IgG cystei... |
|
|
Invention
|
Conditioning regimen for cell transplant. The present invention relates to a conditioning regimen... |
|
2022
|
Invention
|
Methods for enhancing adoptive cell transfer immunotherapies. The present invention relates to me... |
|
|
G/S
|
Pharmaceutical preparations and veterinary preparations for use in the treatment of cancer, autoi... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations;
medicines for human and veterinary purpose... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; medicines for human and veterinary purposes... |
|
2021
|
Invention
|
Cysteine protease.
The present invention relates to a novel polypeptide which displays IgG cyste... |
|
|
Invention
|
Methods for enhancing adoptive cell transfer immunotherapies.
The present invention relates to m... |
|
|
Invention
|
Cysteine protease. in vivoex vivoex vivo uses thereof. Uses of the polypeptide include methods fo... |
|
|
Invention
|
Conditioning regimen for transplant.
The present invention relates to a conditioning regimen for... |
|
|
Invention
|
Conditioning regimen for transplant. The present invention relates to a conditioning regimen for ... |
|
|
Invention
|
Method for improving the benefit to a subject of a therapy or therapeutic agent. The invention re... |
|
|
Invention
|
Immunoglobulin detection and associated therapies.
The present invention relates to improved met... |
|
|
Invention
|
Immunoglobulin detection and associated therapies. The present invention relates to improved meth... |
|
2020
|
G/S
|
Pharmaceutical preparations for use in organ transplantation and for diagnosing, preventing, and ... |
|
2018
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for use in organ transplantation... |
|
|
Invention
|
Diagnostic method for urinary tract infection.
It has been demonstrated that the urinary level o... |
|
2016
|
Invention
|
Diagnostic method for urinary tract infection. It has been demonstrated that the urinary level of... |
|
|
Invention
|
Cysteine proteases. The present invention relates to a novel polypeptide which displays IgG cyste... |
|
2015
|
Invention
|
Method for improving the benefit of organ transplant. The invention relates to a method for impro... |
|
2013
|
Invention
|
Diagnostic method. It has been demonstrated that the level of HBP increases in individuals that s... |
|
|
Invention
|
Diagnostic method.
It has been demonstrated that the level of HBP increases in individuals that ... |
|
2012
|
Invention
|
Treatment for ige-mediated disease. The invention provides an EndoS polypeptide, or a polynucleot... |
|
2011
|
Invention
|
Diagnostic method for bacterial meningitis. It has been demonstrated that the level of HBP increa... |
|
2007
|
Invention
|
Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases. The invention p... |
|
2006
|
Invention
|
Method of treating or preventing a disease or condition mediated by pathogenic igg antibodies. Th... |
|
2003
|
Invention
|
Antimicrobial agent. A method of identifying an agent that enhances the anti-microbial activity o... |
|
1999
|
Invention
|
Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infect... |
|
|
Invention
|
Treatment of bacterial infections. d) determining the clotting time.
An assay for compounds usef... |
